CMMB (STOCKS)
Chemomab Therapeutics Ltd. American Depositary Share
$1.580000
+0.020000 (+1.28%)
Prev close: $1.560000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Adi Mor
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9.73M
- Employees
- 16
- P/E (TTM)
- -0.84
- P/B (TTM)
- 0.85
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2025 (Q1)
|
$-0.56 | $-0.04 | -0.5192 | -1,272.55% |
|
Dec 2024 (Q4)
|
$-0.64 | $-0.32 | -0.3218 | -101.13% |
|
Sep 2024 (Q3)
|
$-0.80 | $-0.02 | -0.7755 | -3,165.31% |
|
Jun 2024 (Q2)
|
$-1.04 | $-0.06 | -0.9829 | -1,721.37% |
Financial Statements
| Operating Expenses | $32.26M |
| Research and Development | $21.12M |
| Other Operating Expenses | $11.14M |
| Income/Loss From Continuing Operations After Tax | -$31.30M |
| Income/Loss From Continuing Operations Before Tax | -$31.81M |
| Income Tax Expense/Benefit | -$513.00K |
| Net Income/Loss | -$31.30M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$31.30M |
| Net Income/Loss Available To Common Stockholders, Basic | -$31.30M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.14 |
| Diluted Earnings Per Share | $0.14 |
| Basic Average Shares | 677,183,107 |
| Diluted Average Shares | 677,183,107 |
| Assets | $35.01M |
| Current Assets | $33.78M |
| Noncurrent Assets | $1.24M |
| Fixed Assets | $352.00K |
| Non-current Prepaid Expenses | $690.00K |
| Other Non-current Assets | $193.00K |
| Liabilities | $7.06M |
| Current Liabilities | $7.00M |
| Wages | $1.50M |
| Other Current Liabilities | $5.50M |
| Noncurrent Liabilities | $62.00K |
| Equity | $27.95M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $27.95M |
| Liabilities And Equity | $35.01M |
| Net Cash Flow From Operating Activities | -$23.85M |
| Net Cash Flow From Operating Activities, Continuing | -$23.85M |
| Net Cash Flow From Investing Activities | $31.58M |
| Net Cash Flow From Investing Activities, Continuing | $31.58M |
| Net Cash Flow From Financing Activities | -$9.38M |
| Net Cash Flow From Financing Activities, Continuing | -$9.38M |
| Net Cash Flow | -$1.65M |
| Net Cash Flow, Continuing | -$1.65M |
| Comprehensive Income/Loss | -$31.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$31.30M |
| Other Comprehensive Income/Loss | $0.00 |